Biomarin Pharmaceutical reported $4.57B in Equity Capital and Reserves for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US USD 425.69M 9.16M
Acorda Therapeutics ACOR:US USD 75.77M 12.14M
Agios Pharmaceuticals AGIO:US USD 1.05B 73.9M
Alnylam Pharmaceuticals ALNY:US USD -67638000 243.68M
Amgen AMGN:US USD 3.65B 1.23B
Bayer BAYN:GR EUR 41.27B 3.25B
Biogen BIIB:US USD 12.78B 903M
Biomarin Pharmaceutical BMRN:US USD 4.57B 63.71M
Bluebird Bio BLUE:US USD 158.86M 21.26M
Gilead Sciences GILD:US USD 21.06B 821M
Insmed INSM:US USD -29959000 74.2M
Intercept Pharmaceuticals ICPT:US USD 107.68M 477.51M
IONIS PHARMACEUT IONS:US USD 594.36M 30.36M
Moderna Inc MRNA:US USD 17.99B 7M
Neurocrine Biosciences NBIX:US USD 1.54B 121.2M
Ptc Therapeutics PTCT:US USD -226904000 44.69M
Puma Biotechnology PBYI:US USD 22.15M 2.42M
Regeneron Pharmaceuticals REGN:US USD 21.44B 751M
Roche Holding ROG:VX 25.19B 700M
Sangamo Biosciences SGMO:US USD 309.15M 9.13M
Sarepta Therapeutics SRPT:US USD 430.84M 295.62M
Seattle Genetics SGEN:US USD 2.82B 111M
Ultragenyx Pharmaceutical RARE:US USD 468.83M 209.24M
United Therapeutics UTHR:US USD 4.56B 243.8M
Vertex Pharmaceuticals VRTX:US USD 13.03B 1.1B
YTE INCY:US USD 4.23B 141.59M